Skip to main content
. 2017 May 12;14(1):453–460. doi: 10.3892/ol.2017.6167

Table I.

Characteristics of the patients (n=24) and tumors (n=39).

Characteristics n (%) Median (range)
Gender
  Male 14 (58.3)
  Female 10 (41.7)
Age, years 64 (43–84)
Performance status
  0 14 (58.3)
  1 10 (41.7)
Primary tumor location
  Right-sided colon   4 (16.7)
  Left-sided colon 14 (58.3)
  Rectum   6 (25.0)
Interval between the initial treatment and radiotherapy, months 34 (5–145)
Number of liver metastasis at the initial radiotherapy
  1 18 (75.0)
  2   4 (16.7)
  3 2 (8.3)
Usage of chemotherapy after initial surgery to radiotherapy
  Yes 21 (87.5)
  No   3 (12.5)
Presence of metastasis at the initial diagnosis
  Yes   8 (33.3)
  No 16 (66.7)
History of local therapya for metastasis
  Yes 16 (66.7)
  No   8 (33.3)
History of chemotherapy
  Yes 21 (87.5)
  No 3 (12.5)
History of radiotherapy
  Yes   4 (16.7)
  No 20 (83.3)
Presence of extra diseases outside the field of radiotherapy
  Yes   5 (20.8)
  No 19 (79.2)
Primary tumor location
  Right-sided colon   7 (17.9)
  Left-sided colon 22 (56.4)
  Rectum 10 (25.6)
GTV, cc 8.7 (0.4–134.7)
Size of maximum diameter, mm 35.6 (7.0–116.9)
  ≤30 18 (46.2)
  30–50 13 (33.3)
  >50   8 (20.5)
PTV, cc 52.8 (12.3–243.0)
Total dose, Gy 56.0 (45.0–72.0)
Number of fractions 8 (4–33)
Fraction size, Gy 7.0 (2.0–12.0)
Total prescription BED10, Gy 97.5 (71.7–115.5)
a

Local therapy included surgery, radiofrequency ablation, and radiotherapy. GTV, gross tumor volume; PTV, planning target volume; BED, biologically effective dose.